Stephens' Rating of Guardant Health on 11/20/2026

On November 20, 2026, Stephens updated its outlook on Guardant Health (NASDAQ:GH) with the action "Reiterated Rating", keeping a "Overweight" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Stephens

DateCompanyAction
11/20/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
Reiterated Rating
11/20/2026
Midland States Bancorp, Inc. stock logo
MSBI
Midland States Bancorp
Reiterated Rating
11/18/2026
Insight Molecular Diagnostics Inc. stock logo
IMDX
Insight Molecular Diagnostics
Reiterated Rating
11/16/2026
Copart, Inc. stock logo
CPRT
Copart
Reiterated Rating
11/16/2026
Codexis, Inc. stock logo
CDXS
Codexis
Reiterated Rating
11/16/2026
CommVault Systems, Inc. stock logo
CVLT
CommVault Systems
Reiterated Rating
More Ratings From Stephens